Ankle–Brachial Index: An Ubiquitous Marker of Cognitive Impairment—The EPIDEMCA Study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Angiology Année : 2018

Ankle–Brachial Index: An Ubiquitous Marker of Cognitive Impairment—The EPIDEMCA Study

(1, 2) , (2, 1, 3) , (2, 4) , (2, 5) , (2) , (2, 3) , (6, 7, 2) , (8) , (6, 2, 7) , (2, 1)
1
2
3
4
5
6
7
8
Pascal M'Belesso
  • Fonction : Auteur
  • PersonId : 905238
Jean François Dartigues
  • Fonction : Auteur
  • PersonId : 960899

Résumé

Epidemiological research on the implication of atherosclerosis in the development of cognitive impairment is lacking in low- and middle-income countries, where two-thirds of the individuals affected by dementia live. Individuals aged ≥65 years living in urban and rural areas of 2 countries in Central Africa were invited. Demographic, clinical, and biological data were collected, and the ankle-brachial index (ABI) was measured. Cognitive impairment was defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria. Among 1662 participants (age 72.9 years, 59.3% females), the prevalence of cognitive impairment was 13.6%, which is higher in individuals with ABI ≤ 0.90 and ABI ≥ 1.40 than those with 0.90 < ABI < 1.40 (20.1% and 17% vs 12%, P = .0024). Cognitive impairment was significantly associated with the factors such as age (odds ratio [OR]: 1.09; 95% confidence interval [CI]: 1.07-1.12, P < .0001), female gender (OR: 2.36, 95% CI: 1.59-3.49, P < .0001), smoking (OR: 1.54, 95% CI: 1.06-2.23, P = .0026), and low ABI (≤0.90; OR: 1.52, 95% CI: 1.03-2.25, P = .0359). The ABI, a ubiquitous marker of atherosclerosis, provides independent and incremental information on susceptibility to present with cognitive disorders.
Fichier non déposé

Dates et versions

hal-01635516 , version 1 (15-11-2017)

Identifiants

Citer

Iléana Desormais, Victor Aboyans, Maëlenn Guerchet, Bébène Ndamba-Bandzouzi, Pascal M'Belesso, et al.. Ankle–Brachial Index: An Ubiquitous Marker of Cognitive Impairment—The EPIDEMCA Study. Angiology, 2018, 69 (6), pp.497-506. ⟨10.1177/0003319717736608⟩. ⟨hal-01635516⟩
37 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More